TNSN07386A1 - Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) - Google Patents
Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)Info
- Publication number
- TNSN07386A1 TNSN07386A1 TNP2007000386A TNSN07386A TNSN07386A1 TN SN07386 A1 TNSN07386 A1 TN SN07386A1 TN P2007000386 A TNP2007000386 A TN P2007000386A TN SN07386 A TNSN07386 A TN SN07386A TN SN07386 A1 TNSN07386 A1 TN SN07386A1
- Authority
- TN
- Tunisia
- Prior art keywords
- tfpi
- administration
- tissue factor
- pathway inhibitor
- factor pathway
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67146605P | 2005-04-15 | 2005-04-15 | |
PCT/US2006/013890 WO2006113360A2 (en) | 2005-04-15 | 2006-04-14 | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor(tfpi) |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN07386A1 true TNSN07386A1 (en) | 2009-03-17 |
Family
ID=36951247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2007000386A TNSN07386A1 (en) | 2005-04-15 | 2007-10-11 | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1871408A2 (ru) |
JP (1) | JP2008536859A (ru) |
KR (1) | KR20080033151A (ru) |
CN (1) | CN101180074A (ru) |
AU (1) | AU2006236698A1 (ru) |
BR (1) | BRPI0610549A2 (ru) |
CA (1) | CA2605057A1 (ru) |
IL (1) | IL186548A0 (ru) |
MX (1) | MX2007012619A (ru) |
RU (1) | RU2007142192A (ru) |
TN (1) | TNSN07386A1 (ru) |
WO (1) | WO2006113360A2 (ru) |
ZA (1) | ZA200708700B (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009129164A1 (en) * | 2008-04-15 | 2009-10-22 | Novartis Ag | Pharmaceutical combinations of tfpi-fragments and an antibiotic |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040040489A (ko) * | 2001-10-15 | 2004-05-12 | 카이론 코포레이션 | 조직 인자 경로 억제제(tfpi)의 저용량 투여에 의한패혈증의 치료 |
-
2006
- 2006-04-14 KR KR1020077026568A patent/KR20080033151A/ko not_active Application Discontinuation
- 2006-04-14 MX MX2007012619A patent/MX2007012619A/es not_active Application Discontinuation
- 2006-04-14 JP JP2008506694A patent/JP2008536859A/ja not_active Withdrawn
- 2006-04-14 CN CNA2006800173396A patent/CN101180074A/zh active Pending
- 2006-04-14 EP EP06750055A patent/EP1871408A2/en not_active Withdrawn
- 2006-04-14 CA CA002605057A patent/CA2605057A1/en not_active Abandoned
- 2006-04-14 RU RU2007142192/14A patent/RU2007142192A/ru not_active Application Discontinuation
- 2006-04-14 WO PCT/US2006/013890 patent/WO2006113360A2/en active Application Filing
- 2006-04-14 BR BRPI0610549-1A patent/BRPI0610549A2/pt not_active IP Right Cessation
- 2006-04-14 AU AU2006236698A patent/AU2006236698A1/en not_active Abandoned
-
2007
- 2007-10-10 IL IL186548A patent/IL186548A0/en unknown
- 2007-10-11 TN TNP2007000386A patent/TNSN07386A1/en unknown
-
2008
- 2008-10-11 ZA ZA200708700A patent/ZA200708700B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101180074A (zh) | 2008-05-14 |
AU2006236698A1 (en) | 2006-10-26 |
RU2007142192A (ru) | 2009-05-20 |
BRPI0610549A2 (pt) | 2010-07-06 |
MX2007012619A (es) | 2008-01-11 |
WO2006113360A2 (en) | 2006-10-26 |
WO2006113360A3 (en) | 2007-04-12 |
KR20080033151A (ko) | 2008-04-16 |
IL186548A0 (en) | 2008-01-20 |
JP2008536859A (ja) | 2008-09-11 |
CA2605057A1 (en) | 2006-10-26 |
ZA200708700B (en) | 2008-12-31 |
EP1871408A2 (en) | 2008-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN07413A1 (en) | Use of tfpi to treat severe bacterial infections | |
MXPA04003548A (es) | Tratamiento de neumonia severa mediante administracion de inhibidor de via factor de tejido. | |
WO2009039397A3 (en) | Substituted amides, methods of making, use thereof for the treatment of diseases such as cancer | |
HK1120409A1 (en) | Treatment of diseases by subcutaneous administration of a vegf antagonist | |
MX346186B (es) | Inhibidores de proteina cinasas. | |
NO20091938L (no) | 7,8-dihydro-1,6-naftyridin-5(6H)-oner og relaterte bicykliske forbindelser som inhibitorer av dipeptidyl-peptidaser IV og metoder | |
WO2009034134A3 (en) | Use of natriuretic peptides for treating angioedema syndromes | |
EA201492010A1 (ru) | Применение высокой дозы лахинимода для лечения рассеянного склероза | |
NO20073830L (no) | Medikamenter for behandling eller forebygging av fibrotiske sykdommer | |
AU2009246603A8 (en) | Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction | |
TW200616644A (en) | Medicine for prevention or treatment of diabetes | |
WO2008008882A3 (en) | Glucocorticoid receptor modulator and methods of use | |
TW200724146A (en) | Use of LGG in the manufacture of a medicament for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant | |
WO2008045378A3 (en) | Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin | |
TW200742580A (en) | Methods for treating nephrolithiasis | |
SG150552A1 (en) | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) | |
TNSN07386A1 (en) | Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi) | |
WO2007104933A8 (en) | Chemical compounds | |
WO2006124544A3 (en) | Use of tyrosine kinase inhibitors in the treatment of metabolic disorders | |
TW200610524A (en) | Medicine for prevention or treatment of diabetes | |
TW200608965A (en) | Medicine for prevention or treatment of diabetes | |
TW200621794A (en) | Pulmonary administration of an antithrombotic compound | |
NO20075898L (no) | Behandling av samfunnsvervet lungebetennelse ved administrering av vevsfaktor pathway inhibitor (TFPI) | |
EA201070844A1 (ru) | ((e)-n-{3-[1-(8-фтор-11h-10-окса-1-аза-дибензо[a,d]циклогептен-5-илиден)пропил]фенил}метансульфонамид) в качестве модулятора рецепторов глюкокортикоидов для лечения ревматизма | |
UA33293U (ru) | Способ лечения хронического эндометрита |